Overview
Ranjini Madhavan is an Internal Medicine provider in Wichita, Kansas. Dr. Madhavan and is rated as an Advanced provider by MediFind in the treatment of Campomelic Dysplasia. Her top areas of expertise are Tetra-Amelia Syndrome, Hypoparathyroidism-Intellectual Disability-Dysmorphism Syndrome, Prader-Willi Syndrome, and Camptodactyly Syndrome Guadalajara Type 2. Dr. Madhavan is currently accepting new patients.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Cigna
- Medica
- Blue Cross Blue Shield
- US Health and Life
- Humana
Locations
3311 E Murdock St, Wichita, KS 67208
1640 E Tall Tree Rd, Via Christi Clinic Pa, Derby, KS 67037
1947 N Founders Cir, Via Christi Clinic Pa, Wichita, KS 67206
818 N Carriage Pkwy, Wichita, KS 67208
2600 Compass Rd, Glenview, IL 60026
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MediFind cannot find any recent clinical research or clinical trials for Dr. Ranjini R. Madhavan
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Advanced
- Aarskog Syndrome
- BOD Syndrome
- Boomerang Dysplasia
- Campomelic Dysplasia
- Camptodactyly Syndrome Guadalajara Type 1
- Camptodactyly Syndrome Guadalajara Type 2
- Experienced
- Allergic Rhinitis
- Asymptomatic Bacteriuria
- Atherosclerosis
- Breast Cancer
- Cellulitis
- Chromophobe Renal Cell Carcinoma